⌘K

Login Start Free

Home/Filings/4/0001628280-21-012173

4//SEC Filing

Kelemen Vicki 4

Accession 0001628280-21-012173

CIK 0001213037other

View on SEC.gov Company Profile

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 4:12 PM ET

Size

5.4 KB

Accession

0001628280-21-012173

Insider Transaction Report

Form 4

Period: 2021-06-10

Cardiff Oncology, Inc.CRDF

Exec. VP and COO

Transactions

Award
Stock Options
2021-06-10+200,928→ 402,768 total
Exercise: $7.98Exp: 2031-06-10→ Common Stock (200,928 underlying)

Footnotes (1)

[F1]50,232 vest on 6/10/2022. 4,186 vest monthly for 36 months beginning on 7/10/2022 through 6/10/2025.

Documents

1 file

4
wf-form4_162370151060627.xmlPrimary
FORM 4

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1

filerCIK 0001815809

Filing Metadata

Form type: 4
Filed: Jun 13, 8:00 PM ET
Accepted: Jun 14, 4:12 PM ET
Size: 5.4 KB

View on SEC.gov